Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Reproductive System > Treatment of Breast Cancer > Flashcards

Treatment of Breast Cancer Flashcards

1
Q

How many women are affected by breast cancer?

A

1 in 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many new cases per year are there of breast cancer in the UK?

A

46,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What number of malignancies in women does breast cancer account for?

A

1/4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What percentage of deaths due to cancer are accounted for by breast cancer?

A

18%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many cases of breast cancer occur in men?

A

Up to 1/100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the biggest risk factor for breast cancer?

A

Age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What members of the MDT team are involved in treatment of breast cancer?

A 
Breast surgeon 
Radiologist
Cytologist
Pathologist
Clinical oncologist
Medical oncologist
Nurse counsellor 
Psychologist 
Reconstructive surgeon 
Patient and partner 
Palliative care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the pathological types of breast cancer?

A

In situ carcinoma

  • ductal carcinoma in situ
  • lobular carcinoma in situ

Invasive carcinoma

  • ductal (70)
  • lobular (25%)
  • tubular
  • cribriform
  • medullary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What aerate two commonest types of breast cancer?

A

Ductal and lobular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What percentage of ductal carcinoma in situ are symptomatic and what percentage are screen detected?

A

3% symptomatic

17% screen detected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What percentage of lobular carcinoma in situ are symptomatic and what percentage are screen detected?

A

0.5% symptomatic

1% screen detected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tubular, cribriform and medullary type breast cancers are cancers of special types, how common are they and what is their prognosis in comparison to breast cancers of no special type?

A

Less common

Better prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How might breast cancer present?

A

Symptomatically or via NHS breast screening programme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the current breast screening programme?

A

Women aged 50-70 invited through GP practice to attend 3 yearly mammogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the principles for management of a patient with breast cancer?

A 
Establish diagnosis 
Assess severity - staging 
Treat underlying cause if possible 
General measures 
Specific measures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you establish the diagnosis of breast cancer?

A 
History and examination 
Ask about risk factors for breast cancer 
Age at first pregnancy 
Breastfeeding 
Radiation exposure 
Weight 
Alcohol consumption 
OCP 
Mammography 
Ultrasound 
Magnetic resonance mammography 
Cytology 
Core biopsy 
Image guided cytology or core biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why is mammography more useful in older women?

A

Breast is denser in younger women, as age increases dense tissue is replaced with fatty tissue which is easier to see

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What should you ask about in FH of a woman with suspected breast cancer?

A

Gene mutations in BRCA1 and BRCA2
Other genes - PTEN, TP53, Li Fraumeni syndrome, Lynch syndrome
Previous cancer in patient or first degree relatives
Ovarian cancer or male breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the risk factors for breast cancer?

A 
Age
Age at menarche and menopause
Age at first pregnancy 
FH 
Previous benign breast disease
Cancer in other breast
Radiation exposure
Lifestyle 
OCP/HRT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What do you look for when suspecting breast cancer?

A

Lump or thickening int he breast, often painless
Discharge or bleeding from nipple
Change in size or contours of breast
Change in colour or appearance of areola
Redness or pitting of skin over the breast (like the skin of an orange)
Paget’s disease of the nipple - can look like eczema or dermatitis

21
Q

What is redness and inflammation with breast cancer known as?

A

Inflammatory cancer

22
Q 
What is the sensitivity of;
clinical examination 
mammography 
ultrasound 
FNA cytology

for breast cancer?

A

Clinical examination 88%
Mammography 93%
Ultrasound 88%
FNA cytology 94%

23
Q

What is the sensitivity?

A

The ability of a test to detect the disease if it is there

24
Q

How do you assess the severity of breast cancer?

A 
Look for metastases 
Hb, FBC, U&Es, LFTs
CXR
Isotope bone scan 
Others as clinically indicated
No reliable tumour markers
25
Q

What is the TNM staging?

A 
T - Tumour 
T1 - 2cm or less
T2 - 2-5cm 
T3 - > 5cm 
T4 - fixed to skin or muscle

N - Nodes
N0 - none
N1 - nodes in axilla
N2 - large or fixed nodes in axilla

M - Metastases
M0 - none
M1 - metastases

26
Q

What are the specific measures in breast cancer management?

A

Primary breast cancer - local control, eradicate disease
Regional tumour-draining nodes - regional control, staging, eradicate disease
Micro-metastases - eradicated disease

27
Q

What are the two main types of surgical procedure done for breast cancer?

A

Breast conservation - wide local excision, quadrantectomy or segmentectomy
Mastectomy

28
Q

Randomised control trials show that tumours measuring 4cm or less can be treated with

A

breast conservation surgery, if > 4cm then mastectomy offered

29
Q

How do you determine what patients are suitable for breast conservation surgery?

A

Tumour size < 4cm
Breast/tumour size ratio - 4cm tumour in small breast would not be suitable as there wouldn’t be breast shape/size left after
Suitable for radiotherapy - always given after breast conservation
Single tumour
Minimal in situ cancer component present
Patient’s wish

30
Q 
In a breast containing a 2cm invasive cancer, what is the risk of other invasive or in situ cancer at a distance of;
1cm 
2cm 
3cm 
4cm

from the tumour that was removed

A

1cm - 60%
2cm - 40%
3cm - 20%
4cm - 10%

31
Q

Why are axillary nodes relevant in breast cancer treatment?

A

Regional control of disease
Staging and prognostic information
Eradicate disease

32
Q

What are the levels of the surgical anatomy of the axilla?

A

Level 1 - below and lateral to pectoralis minor
Level 2 - behind pectoralis minor
Level 3 - above and medial to pectoralis major

33
Q

Why is the sentinel lymph node relevant in breast cancer?

A

First node to receive lymphatic drainage from breast
First node to which tumour spreads
If negative, the rest of the nodes in the lymphatic basin are negative
Skip metastases do not occur

34
Q

What is the treatment of the axilla in breast cancer?

A

If SLN is clear of tumour no further treatment is required
If SLN contains tumour either remove all axillary nodes surgically (axillary clearance) or give radiotherapy to all the nodes in the axilla

35
Q

What is axillary clearance?

A

If sentinel node is involved or patients have FNAC at clinical which shows malignant cells - all nodes removed from axilla
No radiotherapy given, even if nodes are involved with tumour
More morbidity than other types of axillary surgery

36
Q

What are the complications of treatment to the axilla?

A

Lymphoedema
Sensory disturbance
Decreased range of movement of the shoulder joint
Nerve damage - long thoracic, thoracodorsal, brachial plexus
Vascular damage
Radiation-induced sarcoma

37
Q

Who is most likely to have micrometastases and what factors of the disease are associated with increased risk of disease recurrence?

A 
Lymph node involvement 
Tumour grade 3 most aggressive and likely to have micrometastases
Tumour size > 4cm 
Absence of oestrogen receptors 
Presence of HER2 receptors 
Lymphovascular invasion in the tumour
38
Q

What are the treatment choices for micrometastases?

A

Hormone therapy
Chemotherapy
Targeted therapies

39
Q

When is hormone therapy given for micrometastases?

A

Only given if oestrogen receptors are present - oestrogen stimulates tumour growth

40
Q

How do aromatase inhibitors work?

A

Convert androgens into oestrogen - not as useful in younger women

41
Q

What is the hormone therapy for pre-menopausal women with micrometastases?

A

Tamoxifen for 5 years

42
Q

What is the hormone therapy for post-menopausal women with micrometastases?

A

Tamoxifen for 5 years if very good prognosis

If poorer prognosis or more aggressive tumour then use aromatase inhibitor for 5 years

43
Q

What is the hormone therapy in Scotland if the prognosis if intermediate?

A

Tamoxifen for 2 years plus aromatase inhibitor for 3 years

44
Q

When is chemotherapy used in breast cancer?

A

Better effects if age < 50 but older patients still benefit

Given for node positive and grade 3 cancers

45
Q

What are the chemotherapy agents used for breast cancer?

A

Anthracyclines and taxanes

46
Q

What are the risks of chemotherapy for breast cancer?

A

Toxicity

Morbidity and mortality

47
Q

Describe Anti-HER2 therapy

A

Trastuzumab (Herceptin)
Monoclonal antibody against HER-2 receptor given if receptor is present
Given to patients with over-expression of HER2 and chemotherapy
50% decreased risk of recurrence
33% increase in survival at 3 years

48
Q

What is the follow up of breast cancer?

A

Many different protocols, poor evidence base
Clinical examination 6 monthly for 5 years
Yearly clinical examination after this
Discharge after 5 or 10 years
Mammogram of breasts annually for 10 years

Reproductive System (33 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions